• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鼻病毒、呼吸道合胞病毒和蠕虫感染对新发哮喘及其他过敏性疾病风险的影响——欧洲变态反应和临床免疫学会(EAACI)变应性疾病和哮喘环境科学指南的系统评价

The Impact of Rhinovirus, Syncytial Respiratory Virus and Helminth Infection on the Risk of New-Onset Asthma and Other Allergic Conditions-A Systematic Review for the EAACI Guidelines on Environmental Science for Allergic Diseases and Asthma.

作者信息

Agache Ioana, Salazar Josefina, Rodriguez-Tanta Yesenia, Saenz Fiorella Karina Fernandez, Haahtela Tari, Traidl-Hoffmann Claudia, Damialis Athanasios, Vecillas Letizia, Giovannini Mattia, Nadeau Kari C, Pali-Schöll Isabella, Palomares Oscar, Renz Harald, Schwarze Jurgen, Sousa Pinto Bernardo, Urrutia-Pereira Marilyn, Venter Carina, Vercelli Donata, Winders Tonia, Sola-Arnau Ivan, Alonso-Coello Pablo, Canelo-Aybar Carlos, Jutel Marek, Akdis Cezmi A

机构信息

Faculty of Medicine, Transylvania University, Brasov, Romania.

Iberoamerican Cochrane Centre, Barcelona, Spain.

出版信息

Allergy. 2025 Jul;80(7):1878-1898. doi: 10.1111/all.16611. Epub 2025 Jun 10.

DOI:10.1111/all.16611
PMID:40495394
Abstract

This systematic review evaluated the association between lower respiratory tract infections (LRTI) in infancy with respiratory syncytial virus (RSV), rhinovirus (RV) or infestation with helminths and the risk of developing asthma and allergic diseases. The risk of bias was assessed with ROBINS-E, and the certainty of evidence (CoE) with GRADE. Meta-analysis applied a random-effects model. RSV LRTI is likely associated with an increased risk of developing asthma by age 7 (OR 3.02, 95% CI 2.23-4.09; I = 98%; moderate CoE). The impact on wheezing, atopic dermatitis (AD), and allergic rhinitis is uncertain. RV LRTI may be associated with increased risk of developing asthma (OR 8.40, 95% CI 2.56-27.55; I = 43%; low CoE). The impact on wheezing and AD is uncertain. Trichuris trichiura infestation might be associated with reduced risk of new-onset wheezing (OR 0.57, 95% CI 0.35-0.94; very low CoE) or AD (HR: 0.35, 95% CI 0.18-0.67; very low CoE). The association between Ascaris lumbricoides and hookworm infestation and the risk of developing asthma or AD is uncertain. Infestation with any helminths might be associated with reduced risk of new-onset asthma by age 5 (OR: 0.60, 95% CI 0.38-0.95; very low CoE) and wheezing (OR 0.70, 95% CI 0.51-0.95; very low CoE). More high-quality studies are needed to confirm these findings.

摘要

本系统评价评估了婴儿期下呼吸道感染(LRTI)与呼吸道合胞病毒(RSV)、鼻病毒(RV)或蠕虫感染之间的关联以及发生哮喘和过敏性疾病的风险。使用ROBINS-E评估偏倚风险,使用GRADE评估证据确定性(CoE)。荟萃分析采用随机效应模型。RSV LRTI可能与7岁时患哮喘风险增加相关(比值比[OR]3.02,95%置信区间[CI]2.23 - 4.09;I² = 98%;中等CoE)。对喘息、特应性皮炎(AD)和过敏性鼻炎的影响尚不确定。RV LRTI可能与患哮喘风险增加相关(OR 8.40,95% CI 2.56 - 27.55;I² = 43%;低CoE)。对喘息和AD的影响尚不确定。鞭虫感染可能与新发喘息风险降低相关(OR 0.57,95% CI 0.35 - 0.94;极低CoE)或AD(风险比[HR]:0.35,95% CI 0.18 - 0.67;极低CoE)。蛔虫和钩虫感染与患哮喘或AD风险之间的关联尚不确定。任何蠕虫感染可能与5岁时新发哮喘风险降低相关(OR:0.60,95% CI 0.38 - 0.95;极低CoE)和喘息(OR 0.70,95% CI 0.51 - 0.95;极低CoE)。需要更多高质量研究来证实这些发现。

相似文献

1
The Impact of Rhinovirus, Syncytial Respiratory Virus and Helminth Infection on the Risk of New-Onset Asthma and Other Allergic Conditions-A Systematic Review for the EAACI Guidelines on Environmental Science for Allergic Diseases and Asthma.鼻病毒、呼吸道合胞病毒和蠕虫感染对新发哮喘及其他过敏性疾病风险的影响——欧洲变态反应和临床免疫学会(EAACI)变应性疾病和哮喘环境科学指南的系统评价
Allergy. 2025 Jul;80(7):1878-1898. doi: 10.1111/all.16611. Epub 2025 Jun 10.
2
Probiotics in infants for prevention of allergic disease.婴儿使用益生菌预防过敏性疾病。
Cochrane Database Syst Rev. 2025 Jun 13;6(6):CD006475. doi: 10.1002/14651858.CD006475.pub3.
3
Vitamin D supplementation in pregnant or breastfeeding women or young children for preventing asthma.孕期或哺乳期妇女或幼儿补充维生素D以预防哮喘。
Cochrane Database Syst Rev. 2025 Aug 12;8(8):CD013396. doi: 10.1002/14651858.CD013396.pub2.
4
Respiratory syncytial virus vaccination during pregnancy for improving infant outcomes.孕期接种呼吸道合胞病毒疫苗以改善婴儿结局。
Cochrane Database Syst Rev. 2024 May 2;5(5):CD015134. doi: 10.1002/14651858.CD015134.pub2.
5
Palivizumab for preventing severe respiratory syncytial virus (RSV) infection in children.帕利珠单抗预防儿童严重呼吸道合胞病毒(RSV)感染。
Cochrane Database Syst Rev. 2025 Jul 23;7(7):CD013757. doi: 10.1002/14651858.CD013757.pub3.
6
Immunoglobulin treatment for hospitalised infants and young children with respiratory syncytial virus infection.免疫球蛋白治疗住院婴儿和幼儿呼吸道合胞病毒感染。
Cochrane Database Syst Rev. 2023 Oct 23;10(10):CD009417. doi: 10.1002/14651858.CD009417.pub3.
7
Oral and intranasal aspirin desensitisation for non-steroidal anti-inflammatory drug (NSAID)-exacerbated respiratory disease.用于非甾体抗炎药(NSAID)诱发的呼吸道疾病的口服和鼻内阿司匹林脱敏疗法。
Cochrane Database Syst Rev. 2025 Jan 7;1(1):CD013476. doi: 10.1002/14651858.CD013476.pub2.
8
Pulmonary rehabilitation versus usual care for adults with asthma.肺康复治疗与常规护理对哮喘成人的影响比较。
Cochrane Database Syst Rev. 2022 Aug 22;8(8):CD013485. doi: 10.1002/14651858.CD013485.pub2.
9
Beyond respiratory syncytial virus and rhinovirus: The other viral respiratory bandits.除了呼吸道合胞病毒和鼻病毒:其他病毒性呼吸道“强盗”。
Ann Allergy Asthma Immunol. 2025 Sep;135(3):249-260. doi: 10.1016/j.anai.2025.06.012.
10
Non-surgical therapies for Peyronie's disease.非手术治疗 Peyronie 病。
Cochrane Database Syst Rev. 2023 Jul 17;7(7):CD012206. doi: 10.1002/14651858.CD012206.pub2.